After completing this chapter, the reader will be able to:
1.Define terms related to the complications of vascular access devices.
2.Differentiate between local and systemic complications.
3.Describe risk factors and preventive interventions for local complications.
4.Identify noncytotoxic vesicant medications/solutions.
5.Discuss interventions shown to decrease risk for bloodstream infections.
6.Identify risk factors and preventive interventions for systemic complications.
7.Identify complications and risks associated with central vascular access devices.
8.Document relevant information related to vascular access device-related complications.
The placement and the presence of a vascular access device (VAD) put patients at risk for complications during both the insertion process and VAD dwell time. Systemic complications such as catheter-associated bloodstream infection (CABSI), air embolism, and circulatory overload are serious and can be life-threatening, yet are preventable when evidence-based prevention and care practices are employed. The impact of some local complications, such as phlebitis or infiltration, is minimized when the nurse provides thorough and frequent assessments, educates the patient and family members, and identifies early signs and symptoms that allow for prompt action. There are numerous factors that affect the risk for VAD-related complications (Fig. 9-1). These include:
In this chapter, complications are categorized as local, systemic, and central VAD (CVAD) related. The etiology, signs and symptoms, preventive interventions, and treatment are addressed for each complication. Documentation points are also provided.
INS Standard: Vascular access devices are removed when clinically indicated: unresolved complication, discontinuation of infusion therapy, or when no longer necessary for the plan of care (Gorski et al., 2021, p. S133). Clearly complications are prevented when the VAD is removed if no longer needed. Yet in many organizations, a peripheral IV catheter (PIVC) in particular, may be left in place just in case, even if the patient is not receiving active infusions and is able to orally hydrate. Unused or idle IV catheters are common and are associated with adverse outcomes, including increased risk of infection, intensive care unit admission, and phlebitis (Bercerra et al., 2016; Silk et al., 2021).
The nursing process is a six-step process for problem-solving to guide nursing action (see Chapter 1 for details on the steps of the nursing process). The following table focuses on nursing diagnoses, nursing outcomes classification (NOC), and nursing interventions classification (NIC) for patients with local and systemic complications of infusion therapy. Nursing diagnoses should be patient specific and outcomes and interventions individualized. The NOC and NIC presented here are suggested directions for development of specific outcomes and interventions.
Source: Ackley et al., 2020; Herdman et al., 2021.
A 40-year-old woman with insulin-dependent diabetes mellitus is familiar with her disease. She is currently admitted with an infected plantar ulcer and had a transmetatarsal amputation. She was discharged home on a regimen of IV antibiotics via a PICC, with home care follow-up. Case Study Questions1.What potential complications should the home-care nurse be alert for? 2.What documentation needs to be addressed at every visit? 3.What patient education needs to be addressed at home?
|